Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance
Top Cited Papers
Open Access
- 18 May 2020
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (21), 11207-11216
- https://doi.org/10.1073/pnas.1919888117
Abstract
Bacteria frequently encounter selection by both antibiotics and lytic bacteriophages. However, the evolutionary interactions between antibiotics and phages remain unclear, in particular, whether and when phages can drive evolutionary trade-offs with antibiotic resistance. Here, we describe Escherichia coli phage U136B, showing it relies on two host factors involved in different antibiotic resistance mechanisms: 1) the efflux pump protein TolC and 2) the structural barrier molecule lipopolysaccharide (LPS). Since TolC and LPS contribute to antibiotic resistance, phage U136B should select for their loss or modification, thereby driving a trade-off between phage resistance and either of the antibiotic resistance mechanisms. To test this hypothesis, we used fluctuation experiments and experimental evolution to obtain phage-resistant mutants. Using these mutants, we compared the accessibility of specific mutations (revealed in the fluctuation experiments) to their actual success during ecological competition and coevolution (revealed in the evolution experiments). Both tolC and LPS-related mutants arise readily during fluctuation assays, with tolC mutations becoming more common during the evolution experiments. In support of the trade-off hypothesis, phage resistance via tolC mutations occurs with a corresponding reduction in antibiotic resistance in many cases. However, contrary to the hypothesis, some phage resistance mutations pleiotropically confer increased antibiotic resistance. We discuss the molecular mechanisms underlying this surprising pleiotropic result, consideration for applied phage biology, and the importance of ecology in evolution of phage resistance. We envision that phages may be useful for the reversal of antibiotic resistance, but such applications will need to account for unexpected pleiotropy and evolutionary context.Keywords
Funding Information
- National Science Foundation (DBI-0939454)
- HHS | National Institutes of Health (R21AI144345)
- Howard Hughes Medical Institute (52008128)
This publication has 43 references indexed in Scilit:
- Repeatability and Contingency in the Evolution of a Key Innovation in Phage LambdaScience, 2012
- Mechanism and Function of the Outer Membrane Channel TolC in Multidrug Resistance and Physiology of EnterobacteriaFrontiers in Microbiology, 2011
- Antibiotic Sensitivity Profiles Determined with an Escherichia coli Gene Knockout Collection: Generating an Antibiotic Bar CodeAntimicrobial Agents and Chemotherapy, 2010
- Tracing Ancestors and Relatives of Escherichia coli B, and the Derivation of B Strains REL606 and BL21(DE3)Journal of Molecular Biology, 2009
- Outer membrane permeability and antibiotic resistanceBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collectionMolecular Systems Biology, 2006
- PLEIOTROPIC EFFECTS OF BENEFICIAL MUTATIONS IN ESCHERICHIA COLIEvolution, 2005
- The TolC protein of Escherichia coli serves as a cell-surface receptor for the newly characterized TLS bacteriophageJournal of Molecular Biology, 2001
- Resource-Limited Growth, Competition, and Predation: A Model and Experimental Studies with Bacteria and BacteriophageThe American Naturalist, 1977
- CELL WALL COMPOSITION AND VIRULENCE IN ESCHERICHIA COLIThe Journal of Experimental Medicine, 1968